相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and safety of baloxavir marboxil versus neuraminidase inhibitors in the treatment of influenza virus infection in high-risk and uncomplicated patients - a Bayesian network meta-analysis
Vanessa Taieb et al.
CURRENT MEDICAL RESEARCH AND OPINION (2021)
Neuraminidase inhibitors and single dose baloxavir are effective and safe in uncomplicated influenza: a meta-analysis of randomized controlled trials.
Sofia Tejada et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2021)
Recommendations for Prevention and Control of Influenza in Children, 2021-2022
Juan D. Chaparro et al.
PEDIATRICS (2021)
Vaccine Effectiveness Against Influenza Hospitalization Among Children in the United States, 2015-2016
Leora R. Feldstein et al.
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2021)
Effectiveness of influenza vaccine in children in preventing influenza associated hospitalisation, 2018/19, England
R. G. Pebody et al.
VACCINE (2020)
End of season influenza vaccine effectiveness in primary care in adults and children in the United Kingdom in 2018/19
Richard G. Pebody et al.
VACCINE (2020)
A study to evaluate the immunogenicity and shedding of live attenuated influenza vaccine strains in children 24-<48 months of age
Raburn M. Mallory et al.
VACCINE (2020)
Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2017-2018
Emi Takashita et al.
ANTIVIRAL RESEARCH (2020)
Effects of Influenza Vaccination in the United States During the 2018-2019 Influenza Season
Jessie R. Chung et al.
CLINICAL INFECTIOUS DISEASES (2020)
Fever After Influenza, Diphtheria-Tetanus-Acellular Pertussis, and Pneumococcal Vaccinations
Emmanuel B. Walter et al.
PEDIATRICS (2020)
The risk of febrile seizures following influenza and 13-valent pneumococcal conjugate vaccines
Meghan Baker et al.
VACCINE (2020)
The impact of new universal child influenza programs in Australia: Vaccine coverage, effectiveness and disease epidemiology in hospitalised children in 2018
Christopher C. Blyth et al.
VACCINE (2020)
Influenza vaccine effectiveness against influenza-associated hospitalization in children: A systematic review and meta-analysis
Markos Kalligeros et al.
VACCINE (2020)
Global burden of respiratory infections associated with seasonal influenza in children under 5 years in 2018: a systematic review and modelling study
Xin Wang et al.
LANCET GLOBAL HEALTH (2020)
Interim Estimates of 2019–20 Seasonal Influenza Vaccine Effectiveness — United States, February 2020
Fatimah S. Dawood et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Treatment-Emergent Influenza Virus Polymerase Acidic Substitutions Independent of Those at I38 Associated With Reduced Baloxavir Susceptibility and Virus Rebound in Trials of Baloxavir Marboxil
William L. Ince et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Comparison of double-dose vs standard-dose oseltamivir in the treatment of influenza: A systematic review and meta-analysis
Lei Li et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2020)
Baloxavir Marboxil for Prophylaxis against Influenza in Household Contacts
Hideyuki Ikematsu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Baloxavir Marboxil Single-dose Treatment in Influenza-infected Children A Randomized, Double-blind, Active Controlled Phase 3 Safety and Efficacy Trial (miniSTONE-2)
Jeffrey Baker et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2020)
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2020-21 Influenza Season
Lisa A. Grohskopf et al.
MMWR RECOMMENDATIONS AND REPORTS (2020)
Intraseason Waning of Influenza Vaccine Effectiveness
G. Thomas Ray et al.
CLINICAL INFECTIOUS DISEASES (2019)
Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenza
Timothy M. Uyeki et al.
CLINICAL INFECTIOUS DISEASES (2019)
Influenza A(H3N2) virus exhibiting reduced susceptibility to baloxavir due to a polymerase acidic subunit I38T substitution detected from a hospitalised child without prior baloxavir treatment, Japan, January 2019
Emi Takashita et al.
EUROSURVEILLANCE (2019)
Early Use of Anti-influenza Medications in Hospitalized Children With Tracheostomy
Ryo Miyakawa et al.
PEDIATRICS (2019)
Oseltamivir phosphate-Lifting the restriction on its use to treat teenagers with influenza in Japan
Satoshi Takeuchi et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2019)
Baloxavir marboxil susceptibility of influenza viruses from the Asia-Pacific, 2012-2018
Paulina Koszalka et al.
ANTIVIRAL RESEARCH (2019)
Parent Intent and Willingness to Immunize Children Against Influenza in the Pediatric Emergency Department
Rebecca J. Hart et al.
PEDIATRIC EMERGENCY CARE (2019)
Update: Influenza Activity in the United States During the 2018-19 Season and Composition of the 2019-20 Influenza Vaccine
Xiyan Xu et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2019)
Inactivated influenza vaccine and spontaneous abortion in the Vaccine Safety Datalink in 2012-13, 2013-14, and 2014-15
James G. Donahue et al.
VACCINE (2019)
Influenza Vaccine Effectiveness in Preventing Influenza-associated Hospitalizations During Pregnancy: A Multi-country Retrospective Test Negative Design Study, 2010-2016
Mark G. Thompson et al.
CLINICAL INFECTIOUS DISEASES (2019)
Influenza Vaccine Effectiveness
Jill M. Ferdinands et al.
CLINICAL INFECTIOUS DISEASES (2019)
Early Oseltamivir After Hospital Admission Is Associated With Shortened Hospitalization: A 5-Year Analysis of Oseltamivir Timing and Clinical Outcomes
Jeremy Katzen et al.
CLINICAL INFECTIOUS DISEASES (2019)
Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenza
Timothy M. Uyeki et al.
CLINICAL INFECTIOUS DISEASES (2019)
Detection of influenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018
Emi Takashita et al.
EUROSURVEILLANCE (2019)
Assessing baloxavir susceptibility of influenza viruses circulating in the United States during the 2016/17 and 2017/18 seasons
Larisa V. Gubareva et al.
EUROSURVEILLANCE (2019)
Safety and Immunogenicity of a Full-dose, Split-virion, Inactivated, Quadrivalent Influenza Vaccine in Healthy Children 6-35 Months of Age A Randomized Controlled Clinical Trial
Corwin A. Robertson et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2019)
Influenza vaccination during pregnancy for prevention of influenza confirmed illness in the infants: A systematic review and meta-analysis
Marta C. Nunes et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
`Administration of influenza vaccines to egg allergic recipients: A practice parameter update 2017
Matthew Greenhawt et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2018)
A Randomized Study Evaluating the Effectiveness of Oseltamivir Initiated at the Time of Hospital Admission in Adults Hospitalized With Influenza-Associated Lower Respiratory Tract Infections
Julio Ramirez et al.
CLINICAL INFECTIOUS DISEASES (2018)
Oseltamivir Treatment of Influenza in Children
Timothy M. Uyeki
CLINICAL INFECTIOUS DISEASES (2018)
Effectiveness of antiviral treatment in preventing death in severe hospitalised influenza cases over six seasons
A. Dominguez et al.
EPIDEMIOLOGY AND INFECTION (2018)
被撤回的出版物: Influenza Vaccination During Pregnancy (Retracted article. See vol. 131, pg. 751, 2018)
Neil S. Silverman et al.
OBSTETRICS AND GYNECOLOGY (2018)
Maternal Influenza Immunization and Prevention of Severe Clinical Pneumonia in Young Infants Analysis of Randomized Controlled Trials Conducted in Nepal, Mali and South Africa
Saad B. Omer et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2018)
Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil
Shinya Omoto et al.
SCIENTIFIC REPORTS (2018)
Cost-effectiveness of Strategies for Offering Influenza Vaccine in the Pediatric Emergency Department
Rebecca J. Hart et al.
JAMA PEDIATRICS (2018)
Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) — United States, 2018–19 Influenza Season
Lisa A. Grohskopf et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2018)
Update: Influenza Activity in the United States During the 2017–18 Season and Composition of the 2018–19 Influenza Vaccine
Rebecca Garten et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2018)
Influenza-Associated Acute Necrotizing Encephalopathy in Siblings
Ashley Howard et al.
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2018)
Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents
Frederick G. Hayden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Safety and immunogenicity of seasonal trivalent inactivated influenza vaccines in pregnant women
Flor M. Munoz et al.
VACCINE (2018)
Efficacy and Safety of Oseltamivir in Children: Systematic Review and Individual Patient Data Meta-analysis of Randomized Controlled Trials
Ryan E. Malosh et al.
CLINICAL INFECTIOUS DISEASES (2018)
Prevention of vaccine-matched and mismatched influenza in children aged 6-35 months: a multinational randomised trial across five influenza seasons
Carine Claeys et al.
LANCET CHILD & ADOLESCENT HEALTH (2018)
Systematic Assessment of Multiple Routine and Near Real-Time Indicators to Classify the Severity of Influenza Seasons and Pandemics in the United States, 2003-2004 Through 2015-2016
Matthew Biggerstaff et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2018)
Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial
Mark C. Steinhoff et al.
LANCET INFECTIOUS DISEASES (2017)
Intravenous Zanamivir in Hospitalized Patients With Influenza
John S. Bradley et al.
PEDIATRICS (2017)
The Concordance of Parent and Child Immunization
Steve G. Robison et al.
PEDIATRICS (2017)
Influenza Vaccine Effectiveness Against Pediatric Deaths: 2010-2014
Brendan Flannery et al.
PEDIATRICS (2017)
Waning protection of influenza vaccination during four influenza seasons, 2011/2012 to 2014/2015
J. Puig-Barbera et al.
VACCINE (2017)
Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010-11 and 2011-12
James G. Donahue et al.
VACCINE (2017)
Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection
R G Pebody et al.
Eurosurveillance (2017)
Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case–control study
E Kissling et al.
Eurosurveillance (2017)
Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12
J Castilla et al.
Eurosurveillance (2017)
Impact of Outpatient Neuraminidase Inhibitor Treatment in Patients Infected With Influenza A(H1N1)pdm09 at High Risk of Hospitalization: An Individual Participant Data Metaanalysis
Sudhir Venkatesan et al.
CLINICAL INFECTIOUS DISEASES (2017)
A case-control study of risk factors for death from 2009 pandemic influenza A(H1N1): is American Indian racial status an independent risk factor?
T. W. Hennessy et al.
EPIDEMIOLOGY AND INFECTION (2016)
A randomized, double-blind, placebo-controlled trial evaluating the safety of early oseltamivir treatment among children 0-9 years of age hospitalized with influenza in El Salvador and Panama
Fatimah S. Dawood et al.
ANTIVIRAL RESEARCH (2016)
I-MOVE multicentre case-control study 2010/11 to 2014/15: Is there within-season waning of influenza type/subtype vaccine effectiveness with increasing time since vaccination?
E. Kissling et al.
EUROSURVEILLANCE (2016)
Modest Waning of Influenza Vaccine Efficacy and Antibody Titers During the 2007-2008 Influenza Season
Joshua G. Petrie et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial
Milagritos D. Tapia et al.
LANCET INFECTIOUS DISEASES (2016)
Febrile Seizure Risk After Vaccination in Children 6 to 23 Months
Jonathan Duffy et al.
PEDIATRICS (2016)
Influenza in Infants Born to Women Vaccinated During Pregnancy
Julie H. Shakib et al.
PEDIATRICS (2016)
Safety of the 2010-11, 2011-12, 2012-13, and 2013-14 seasonal influenza vaccines in pregnancy: Birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants, a study from the cohort arm of VAMPSS
Christina D. Chambers et al.
VACCINE (2016)
Influenza vaccine effectiveness: Maintained protection throughout the duration of influenza seasons 2010-2011 through 2013-2014
Jennifer M. Radin et al.
VACCINE (2016)
Clinical experience with intravenous zanamivir under an Emergency IND program in the United States (2011-2014)
Kirk M. Chan-Tack et al.
ANTIVIRAL THERAPY (2015)
Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials
Joanna Dobson et al.
LANCET (2015)
Maternal Influenza Vaccination and Risk for Congenital Malformations A Systematic Review and Meta-analysis
Konstantinos A. Polyzos et al.
OBSTETRICS AND GYNECOLOGY (2015)
Waning vaccine protection against influenza A (H3N2) illness in children and older adults during a single season
Edward A. Belongia et al.
VACCINE (2015)
Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age
Natasha B. Halasa et al.
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2015)
Vaccine safety signal from spontaneous system not supported by active surveillance
Cheryl A. Thompson
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2014)
Effectiveness of Influenza Vaccine Against Life-threatening RT-PCR-confirmed Influenza Illness in US Children, 2010-2012
Jill M. Ferdinands et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Maternal Influenza Vaccine and Risks for Preterm or Small for Gestational Age Birth
James D. Nordin et al.
JOURNAL OF PEDIATRICS (2014)
Influenza Vaccination of Pregnant Women and Protection of Their Infants
Shabir A. Madhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data
Stella G. Muthuri et al.
LANCET RESPIRATORY MEDICINE (2014)
Influenza Hospitalizations Among American Indian/Alaska Native People and in the United States General Population
Prabhu P. Gounder et al.
OPEN FORUM INFECTIOUS DISEASES (2014)
Update on influenza vaccination of egg allergic patients
John M. Kelso et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2013)
IgA and Neutralizing Antibodies to Influenza A Virus in Human Milk: A Randomized Trial of Antenatal Influenza Immunization
Elizabeth P. Schlaudecker et al.
PLOS ONE (2013)
Neuraminidase Inhibitors for Critically Ill Children With Influenza
Janice K. Louie et al.
PEDIATRICS (2013)
Risks and safety of pandemic h1n1 influenza vaccine in pregnancy: Birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants
Christina D. Chambers et al.
VACCINE (2013)
Antivirals for Treatment of Influenza A Systematic Review and Meta-analysis of Observational Studies
Jonathan Hsu et al.
ANNALS OF INTERNAL MEDICINE (2012)
Effect of Influenza Vaccination in the First Trimester of Pregnancy
Jeanne S. Sheffield et al.
OBSTETRICS AND GYNECOLOGY (2012)
Immunizing Parents and Other Close Family Contacts in the Pediatric Office Setting
Herschel R. Lessin et al.
PEDIATRICS (2012)
Racial and Ethnic Disparities in Hospitalizations and Deaths Associated with 2009 Pandemic Influenza A (H1N1) Virus Infections in the United States
Deborah L. Dee et al.
ANNALS OF EPIDEMIOLOGY (2011)
Effectiveness of maternal influenza immunization in mothers and infants
K. Zaman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
分享论文
